These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 834212)

  • 1. Aspirin-induced depression of renal function.
    Kimberly RP; Plotz PH
    N Engl J Med; 1977 Feb; 296(8):418-24. PubMed ID: 834212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of low dose aspirin in elderly patients.
    Segal R; Lubart E; Leibovitz A; Iaina A; Caspi D
    Isr Med Assoc J; 2006 Oct; 8(10):679-82. PubMed ID: 17125112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.
    Caspi D; Lubart E; Graff E; Habot B; Yaron M; Segal R
    Arthritis Rheum; 2000 Jan; 43(1):103-8. PubMed ID: 10643705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Haemodialysis for renal failure in a case of systemic lupus erythematosus (author's transl)].
    Schmidt P; Kopsa H; Zazgornik J
    Dtsch Med Wochenschr; 1975 Jun; 100(24):1335-7. PubMed ID: 1079489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of renal function with selective thromboxane antagonism in lupus nephritis.
    Pierucci A; Simonetti BM; Pecci G; Mavrikakis G; Feriozzi S; Cinotti GA; Patrignani P; Ciabattoni G; Patrono C
    N Engl J Med; 1989 Feb; 320(7):421-5. PubMed ID: 2643773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reevaluation of aspirin therapy in rheumatoid arthritis.
    Fries JF; Ramey DR; Singh G; Morfeld D; Bloch DA; Raynauld JP
    Arch Intern Med; 1993 Nov; 153(21):2465-71. PubMed ID: 8215751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arthritis and nephritis in patients with systemic lupus erythematosus.
    Kaplan D; Ginzler EM; Feldman J
    J Rheumatol; 1991 Feb; 18(2):223-9. PubMed ID: 2023215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus.
    Kimberly RP; Gill JR; Bowden RE; Keiser HR; Plotz PH
    Ann Intern Med; 1978 Sep; 89(3):336-41. PubMed ID: 686544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
    Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
    Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in systemic lupus erythematosus. Association with other immunologic abnormalities but not with changes in renal function.
    Huston KA; Gupta RC; Donadio JV; McDuffie FC; Ilstrup DM
    J Rheumatol; 1978; 5(4):423-32. PubMed ID: 310885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum concentrations of pro-gastrin-releasing peptide in patients with renal dysfunction.
    Kamata K; Uchida M; Takeuchi Y; Takahashi E; Sato N; Miyake Y; Okubo M; Kodama T; Yamaguchi K
    Nephrol Dial Transplant; 1996 Jul; 11(7):1267-70. PubMed ID: 8672021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
    Tateno S; Kobayashi Y; Shigematsu H; Hiki Y
    Q J Med; 1983; 52(207):311-31. PubMed ID: 6359226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
    Edwards W
    Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM; El-Kerdany TH
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY; Holliday SL; Williams P; Brey RL
    Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial drug induced decrease in creatinine clearance.
    Landewé RB; Vergouwen MS; Goeei The SG; Van Rijthoven AW; Breedveld FC; Dijkmans BA
    J Rheumatol; 1995 Jan; 22(1):34-7. PubMed ID: 7699677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of etodolac in subjects with renal impairment.
    Brater DC
    Eur J Rheumatol Inflamm; 1990; 10(1):44-55. PubMed ID: 2146131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.